Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine

Norio Ogawa, Masato Asanuma, Yoichi Kondo, Yoshiro Kawada, Mitsutoshi Yamamoto, Akitane Mori

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Whether or not chronic l-DOPA treatment (100 mg/kg, intraperitoneally (i.p.), twice daily for 4 weeks) alters lipid peroxidation in the brain as an indicator of neuronal damage was examined in normal mice and mice in which catecholamine (CA) neurons had been injured previously by the administration of 6-hydroxydopamine (6-OHDA), followed by recovery. In normal mice, chronic l-DOPA treatment reduced the thiobarbituric acid reacting substances (TBARS) level, an indicator of lipid peroxidation, in the cerebral cortex. In contrast, in mice with CA neuronal injury induced by pretreatment with 6-OHDA, the chronic l-DOPA treatment markedly increased the TBARS in the striatum and frontal cortex, despite recovery of the striatal dopamine levels similar to those in the control mice. These findings suggest that the long-term high-dose administration of l-DOPA enhances the progression of neuronal damage in patients with injured CA neurons such as those with Parkinson's disease.

Original languageEnglish
Pages (from-to)55-58
Number of pages4
JournalNeuroscience Letters
Volume171
Issue number1-2
DOIs
Publication statusPublished - Apr 25 1994

Fingerprint

Oxidopamine
Lipid Peroxidation
Brain
Catecholamines
Therapeutics
Neurons
Corpus Striatum
Frontal Lobe
Cerebral Cortex
Parkinson Disease
Dopamine
Wounds and Injuries
thiobarbituric acid

Keywords

  • 6-Hydroxydopamine
  • Catecholamine
  • Dopamine
  • l-DOPA
  • Lipid peroxidation
  • Neuronal damage
  • Parkinson's disease
  • Thiobarbituric acid reacting substances (TBARS)

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine. / Ogawa, Norio; Asanuma, Masato; Kondo, Yoichi; Kawada, Yoshiro; Yamamoto, Mitsutoshi; Mori, Akitane.

In: Neuroscience Letters, Vol. 171, No. 1-2, 25.04.1994, p. 55-58.

Research output: Contribution to journalArticle

Ogawa, Norio ; Asanuma, Masato ; Kondo, Yoichi ; Kawada, Yoshiro ; Yamamoto, Mitsutoshi ; Mori, Akitane. / Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine. In: Neuroscience Letters. 1994 ; Vol. 171, No. 1-2. pp. 55-58.
@article{54055a2336cd418b9386b8c337aaab95,
title = "Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine",
abstract = "Whether or not chronic l-DOPA treatment (100 mg/kg, intraperitoneally (i.p.), twice daily for 4 weeks) alters lipid peroxidation in the brain as an indicator of neuronal damage was examined in normal mice and mice in which catecholamine (CA) neurons had been injured previously by the administration of 6-hydroxydopamine (6-OHDA), followed by recovery. In normal mice, chronic l-DOPA treatment reduced the thiobarbituric acid reacting substances (TBARS) level, an indicator of lipid peroxidation, in the cerebral cortex. In contrast, in mice with CA neuronal injury induced by pretreatment with 6-OHDA, the chronic l-DOPA treatment markedly increased the TBARS in the striatum and frontal cortex, despite recovery of the striatal dopamine levels similar to those in the control mice. These findings suggest that the long-term high-dose administration of l-DOPA enhances the progression of neuronal damage in patients with injured CA neurons such as those with Parkinson's disease.",
keywords = "6-Hydroxydopamine, Catecholamine, Dopamine, l-DOPA, Lipid peroxidation, Neuronal damage, Parkinson's disease, Thiobarbituric acid reacting substances (TBARS)",
author = "Norio Ogawa and Masato Asanuma and Yoichi Kondo and Yoshiro Kawada and Mitsutoshi Yamamoto and Akitane Mori",
year = "1994",
month = "4",
day = "25",
doi = "10.1016/0304-3940(94)90603-3",
language = "English",
volume = "171",
pages = "55--58",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Differential effects of chronic l-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine

AU - Ogawa, Norio

AU - Asanuma, Masato

AU - Kondo, Yoichi

AU - Kawada, Yoshiro

AU - Yamamoto, Mitsutoshi

AU - Mori, Akitane

PY - 1994/4/25

Y1 - 1994/4/25

N2 - Whether or not chronic l-DOPA treatment (100 mg/kg, intraperitoneally (i.p.), twice daily for 4 weeks) alters lipid peroxidation in the brain as an indicator of neuronal damage was examined in normal mice and mice in which catecholamine (CA) neurons had been injured previously by the administration of 6-hydroxydopamine (6-OHDA), followed by recovery. In normal mice, chronic l-DOPA treatment reduced the thiobarbituric acid reacting substances (TBARS) level, an indicator of lipid peroxidation, in the cerebral cortex. In contrast, in mice with CA neuronal injury induced by pretreatment with 6-OHDA, the chronic l-DOPA treatment markedly increased the TBARS in the striatum and frontal cortex, despite recovery of the striatal dopamine levels similar to those in the control mice. These findings suggest that the long-term high-dose administration of l-DOPA enhances the progression of neuronal damage in patients with injured CA neurons such as those with Parkinson's disease.

AB - Whether or not chronic l-DOPA treatment (100 mg/kg, intraperitoneally (i.p.), twice daily for 4 weeks) alters lipid peroxidation in the brain as an indicator of neuronal damage was examined in normal mice and mice in which catecholamine (CA) neurons had been injured previously by the administration of 6-hydroxydopamine (6-OHDA), followed by recovery. In normal mice, chronic l-DOPA treatment reduced the thiobarbituric acid reacting substances (TBARS) level, an indicator of lipid peroxidation, in the cerebral cortex. In contrast, in mice with CA neuronal injury induced by pretreatment with 6-OHDA, the chronic l-DOPA treatment markedly increased the TBARS in the striatum and frontal cortex, despite recovery of the striatal dopamine levels similar to those in the control mice. These findings suggest that the long-term high-dose administration of l-DOPA enhances the progression of neuronal damage in patients with injured CA neurons such as those with Parkinson's disease.

KW - 6-Hydroxydopamine

KW - Catecholamine

KW - Dopamine

KW - l-DOPA

KW - Lipid peroxidation

KW - Neuronal damage

KW - Parkinson's disease

KW - Thiobarbituric acid reacting substances (TBARS)

UR - http://www.scopus.com/inward/record.url?scp=0028343897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028343897&partnerID=8YFLogxK

U2 - 10.1016/0304-3940(94)90603-3

DO - 10.1016/0304-3940(94)90603-3

M3 - Article

VL - 171

SP - 55

EP - 58

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -